LionBird — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Phantom Neurophantomneuro.comin𝕏Mar 2022
Phantom Neuro develops a minimally invasive, subcutaneous muscle-computer interface that uses under-the-skin sensors and on-device AI to translate muscle signals into control commands for robotic devices.
AI & Machine LearningBiotechMedical DevicesRoboticsAustin, US
Connor Glass(Executive Officer, Director, Promoter)in
BoardD.A. Wallach(Director)inEdward Michael(Director)in
Board seatRobert Lord· per SEC Form D
Co-investorsBreakout VenturesDraper AssociatesTime BioVentures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.